Protea Biosciences Group, Inc. — Net Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/60ef36d3-ff31-4d62-bda9-57a3b874e368/serie/net-income

Fiscal year	Net Income	Period	Evidence
FY 2016	$-15.6M	2016-01-01 – 2016-12-31	evidence 0001144204-17-020500
FY 2015	$-9.6M	2015-01-01 – 2015-12-31	evidence 0001144204-16-088486
FY 2014	$-11.5M	2014-01-01 – 2014-12-31	evidence 0001144204-15-009007
FY 2013	$-61.1M	2001-07-13 – 2014-03-31	evidence 0001144204-14-028814
FY 2012	$-49.6M	2001-07-13 – 2013-03-31	evidence 0001144204-13-027996
FY 2011	$-40.4M	2001-06-13 – 2012-03-31	evidence 0001144204-12-028704
FY 2010	$-9.6M	2010-01-01 – 2010-12-31	evidence 0001144204-12-018104
FY 2009	$-5.3M	2009-01-01 – 2009-12-31	evidence 0001144204-12-018104
FY 2008	$-4.0M	2008-01-01 – 2008-12-31	evidence 0001144204-12-018104
FY 2007	$-2.9M	2007-01-01 – 2007-12-31	evidence 0001144204-12-018104
FY 2006	$-1.3M	2006-01-01 – 2006-12-31	evidence 0001144204-12-018104
FY 2005	$-1.0M	2005-01-01 – 2005-12-31	evidence 0001144204-12-018104
FY 2004	$-459.5k	2004-01-01 – 2004-12-31	evidence 0001144204-12-018104
FY 2003	$-420.4k	2003-01-01 – 2003-12-31	evidence 0001144204-12-018104
FY 2002	$-416.5k	2002-01-01 – 2002-12-31	evidence 0001144204-12-018104

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Protea Biosciences Group, Inc. — all facts · Revenue · Operating Income